Denka Co Ltd
TSE:4061

Watchlist Manager
Denka Co Ltd Logo
Denka Co Ltd
TSE:4061
Watchlist
Price: 2 172.5 JPY -0.82% Market Closed
Market Cap: 187.2B JPY
Have any thoughts about
Denka Co Ltd?
Write Note

Denka Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Denka Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Denka Co Ltd
TSE:4061
Change in Working Capital
ÂĄ11.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Asahi Kasei Corp
TSE:3407
Change in Working Capital
-ÂĄ55.5B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
-18%
Kuraray Co Ltd
TSE:3405
Change in Working Capital
-ÂĄ24.8B
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
-3%
Toray Industries Inc
TSE:3402
Change in Working Capital
-ÂĄ20.3B
CAGR 3-Years
33%
CAGR 5-Years
-14%
CAGR 10-Years
8%
Mitsui Chemicals Inc
TSE:4183
Change in Working Capital
ÂĄ12.8B
CAGR 3-Years
N/A
CAGR 5-Years
0%
CAGR 10-Years
N/A
T
Tosoh Corp
TSE:4042
Change in Working Capital
-ÂĄ30B
CAGR 3-Years
29%
CAGR 5-Years
-3%
CAGR 10-Years
2%
No Stocks Found

Denka Co Ltd
Glance View

Market Cap
187.2B JPY
Industry
Chemicals

Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.

Intrinsic Value
2 498 JPY
Undervaluation 13%
Intrinsic Value
Price

See Also

What is Denka Co Ltd's Change in Working Capital?
Change in Working Capital
11.5B JPY

Based on the financial report for Sep 30, 2024, Denka Co Ltd's Change in Working Capital amounts to 11.5B JPY.

Back to Top